Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DB25FYQVC
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $20,605
Award facts
- Contract value 100% obligated
- $20,604.63 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $20,604.63 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 ml pen injectors. This firm fixed-price contract, awarded on September 15, 2025, represents a non-competitive, non-set-aside delivery order with an ultimate completion date of September 16, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate office location. Dupixent (dupilumab) is a monoclonal antibody used to treat moderate-to-severe atopic dermatitis, eosinophilic esophagitis, and asthma, making this a specialized pharmaceutical procurement supporting military healthcare requirements.
This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026. This comprehensive global pharmaceutical support vehicle enables the company to supply a wide range of brand-name and generic medications, vaccines, and medical supplies to support military healthcare programs worldwide, including customers such as the Defense Health Agency and U.S. Coast Guard. As a major pharmaceutical distributor, AmerisourceBergen Drug Corp has demonstrated capability to meet federal procurement requirements through open competition and continues to serve as a critical vendor for the military medical supply chain.
Quick answers
Who was awarded contract SPE2DB25FYQVC?
SPE2DB25FYQVC was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 15, 2025.
How much is contract SPE2DB25FYQVC worth?
The government has obligated $20,605 on SPE2DB25FYQVC.
Is contract SPE2DB25FYQVC an order under another contract?
Yes. SPE2DB25FYQVC is a delivery order under SPE2DB22D1017, an indefinite delivery contract.
Was contract SPE2DB25FYQVC competed?
The extent of competition for SPE2DB25FYQVC was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award